131 related articles for article (PubMed ID: 20555001)
1. Matrix metalloproteinases 2 and 9 and their tissue inhibitors in the follicular fluid of patients with polycystic ovaries undergoing in vitro fertilisation.
Baka S; Zourla K; Kouskouni E; Makrakis E; Demeridou S; Tzanakaki D; Hassiakos D; Creatsas G
In Vivo; 2010; 24(3):293-6. PubMed ID: 20555001
[TBL] [Abstract][Full Text] [Related]
2. Intrafollicular levels of matrix metalloproteinases-2 and -9 in patients with polycystic ovaries are not associated with pregnancy rate during IVF cycle.
Baka S; Zourla K; Malamitsi-Puchner A; Makrakis E; Kaparos G; Demeridou S; Moustakarias T; Tzanakaki D; Hassiakos D; Kouskouni E
In Vivo; 2009; 23(1):89-92. PubMed ID: 19368130
[TBL] [Abstract][Full Text] [Related]
3. The expression of matrix metalloproteinase-9 in human follicular fluid is associated with in vitro fertilisation pregnancy.
Lee DM; Lee TK; Song HB; Kim CH
BJOG; 2005 Jul; 112(7):946-51. PubMed ID: 15957997
[TBL] [Abstract][Full Text] [Related]
4. Comparative assessment of matrix metalloproteinase (MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension.
Palei AC; Sandrim VC; Cavalli RC; Tanus-Santos JE
Clin Biochem; 2008 Jul; 41(10-11):875-80. PubMed ID: 18477480
[TBL] [Abstract][Full Text] [Related]
5. Serum and follicular resistin levels in women with polycystic ovarian syndrome during IVF-stimulated cycles.
Seow KM; Juan CC; Hsu YP; Ho LT; Wang YY; Hwang JL
Hum Reprod; 2005 Jan; 20(1):117-21. PubMed ID: 15513972
[TBL] [Abstract][Full Text] [Related]
6. Decreased expression of tissue inhibitor of matrix metalloproteinases in follicular fluid from women with polycystic ovaries compared with normally ovulating patients undergoing in vitro fertilization.
Lahav-Baratz S; Kraiem Z; Shiloh H; Koifman M; Ishai D; Dirnfeld M
Fertil Steril; 2003 Mar; 79(3):567-71. PubMed ID: 12620441
[TBL] [Abstract][Full Text] [Related]
7. Secretion of matrix metalloproteinases 2 and 9 and tissue inhibitor of metalloproteinases into follicular fluid during follicle development in equine ovaries.
Riley SC; Gibson AH; Leask R; Mauchline DJ; Pedersen HG; Watson ED
Reproduction; 2001 Apr; 121(4):553-60. PubMed ID: 11277874
[TBL] [Abstract][Full Text] [Related]
8. Serum matrix metalloproteinase and tissue inhibitor of metalloproteinase concentrations in infertile women achieved pregnancy following IVF-ET.
Shibahara H; Suzuki T; Kikuchi K; Hirano Y; Suzuki M
Am J Reprod Immunol; 2005 Oct; 54(4):186-92. PubMed ID: 16135009
[TBL] [Abstract][Full Text] [Related]
9. Intrafollicular expression of matrix metalloproteinases and their inhibitors in normally ovulating women compared with patients undergoing in vitro fertilization treatment.
D'Ascenzo S; Giusti I; Millimaggi D; Marci R; Tatone C; Cardigno Colonna R; Moscarini M; Pavan A; Dolo V; Caserta D
Eur J Endocrinol; 2004 Jul; 151(1):87-91. PubMed ID: 15248826
[TBL] [Abstract][Full Text] [Related]
10. MMP/TIMP imbalance in amniotic fluid during PROM: an indirect support for endogenous pathway to membrane rupture.
Fortunato SJ; Menon R; Lombardi SJ
J Perinat Med; 1999; 27(5):362-8. PubMed ID: 10642956
[TBL] [Abstract][Full Text] [Related]
11. Resistin levels of serum and follicular fluid in non-obese patients with polycystic ovary syndrome during IVF cycles.
Lu XE; Huang HF; Li MG; Zhu YM; Qiang YL; Dong MY
J Zhejiang Univ Sci B; 2005 Sep; 6(9):897-902. PubMed ID: 16130192
[TBL] [Abstract][Full Text] [Related]
12. Characterization of matrix metalloproteinase-2 and matrix metalloproteinase-9 and their inhibitors in equine granulosa cells in vivo and in vitro.
Sessions DR; Vick MM; Fitzgerald BP
J Anim Sci; 2009 Dec; 87(12):3955-66. PubMed ID: 19684269
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between matrix metalloproteinases (MMP-9 and MMP-2) and tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2) in acute respiratory distress syndrome patients.
Lanchou J; Corbel M; Tanguy M; Germain N; Boichot E; Theret N; Clement B; Lagente V; Malledant Y
Crit Care Med; 2003 Feb; 31(2):536-42. PubMed ID: 12576963
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of the clinical outcomes of IVF-ET treatment in infertile patients with polycystic ovary syndrome or polycystic ovaries].
Wang QL; Song J; Chen SL; Luo C; Chen X; Li M; Ni YP
Nan Fang Yi Ke Da Xue Xue Bao; 2009 May; 29(5):962-5. PubMed ID: 19460721
[TBL] [Abstract][Full Text] [Related]
15. [Expression of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in the hepatocellular carcinomas].
Wei QY; Wu YQ; Fan SQ
Hunan Yi Ke Da Xue Xue Bao; 2003 Jun; 28(3):212-6. PubMed ID: 14653069
[TBL] [Abstract][Full Text] [Related]
16. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A
Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412
[TBL] [Abstract][Full Text] [Related]
17. The balance between MMP-9 and MMP-2 and their tissue inhibitor (TIMP)-1 in luteinized granulosa cells: comparison between women with PCOS and normal ovulatory women.
Shalev E; Goldman S; Ben-Shlomo I
Mol Hum Reprod; 2001 Apr; 7(4):325-31. PubMed ID: 11279294
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats.
Zhang X; Sakamoto T; Hata Y; Kubota T; Hisatomi T; Murata T; Ishibashi T; Inomata H
Exp Eye Res; 2002 May; 74(5):577-84. PubMed ID: 12076079
[TBL] [Abstract][Full Text] [Related]
19. [The role of disequilibrium of expression of matrix metalloproteinase-2/9 and their tissue inhibitors in pathogenesis of hyperoxia-induced acute lung injury in mice].
Zhang XF; Zhu GF; Liu S; Foda HD
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2008 Oct; 20(10):597-600. PubMed ID: 18926070
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases-2 and -9 and their endogenous tissue inhibitors in tissue remodeling after sealing of the fetal membranes in a sheep model of fetoscopic surgery.
Devlieger R; Riley SC; Verbist L; Leask R; Pijnenborg R; Deprest JA
J Soc Gynecol Investig; 2002; 9(3):137-45. PubMed ID: 12009387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
